Copenhagen Bioengineering ApS: Financial statements 2017
CVR: 37640549
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Copenhagen Bioengineering ApS (CVR 37640549) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 52,632 and a net result of DKK 51,472. Equity in the 2017 report amounted to DKK 48,322. The solvency ratio was 83.4%.
- Gross Profit
- DKK 52,632
- Profit/Loss
- DKK 51,472
- Equity
- DKK 48,322
- Total Assets
- DKK 57,938
Official annual report
Keep an eye on Copenhagen Bioengineering ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Copenhagen Bioengineering ApS has published its interim report for the period April 26, 2016 – December 31, 2016.
About Copenhagen Bioengineering ApS
Copenhagen Bioengineering ApS is a Danish company of the type Anpartsselskab based in Hårlev, founded in 2016. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The management consists of Phillip Falkenløve Kaaber and Marco Falkenløve Kaaber. The board consists of Niels Juul Jensen. The company's owners include Strukturforsyningen ApS, Holtug Holding ApS and M.F. Kaaber Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -90,560 and a net result of DKK -210,012 compared with DKK 27,263 the year before. Equity in the 2025 report amounted to DKK 808,561.